Literature DB >> 12602272

[The incidence of human papilloma virus (HPV) DNA in patients with cervical carcinoma from Gdansk region].

Joanna Liss1, Krzysztof Łukaszuk, Jacek Gulczyński, Mariusz Zwaliński, Izabela Woźniak, Janusz Emerich, Czesław Wójcikowski.   

Abstract

OBJECTIVES: We have estimated the incidence of human papilloma virus (HPV) DNA in cervical smears of patients with cervical carcinoma, treated in 1997-1998 at the II Department of Obstetrics and Gynecology, Medical University of Gdańsk, Poland.
MATERIALS AND METHODS: We have examined 107 patients suffering from cervical cancer. The HPV DNA was detected with the polymerase chain reaction (PCR) method using two primer pairs located in the E6, E7 open reading frames. HPV typing was executed by restriction fragments length polymorphism PCR (RFLP-PCR) method.
RESULTS: HPV DNA was detected in 75 (70.1%) patients. A group of patients with Ib (43%) and IIa (19.6%) clinical degrees made the highest percentage within the research group. We found no statistically significant differences between various clinical degrees of cervical cancer in the group of patients both HPV positive and negative.
CONCLUSIONS: The frequency of HPV especially HPV 16 type infection incidence in cervical carcinoma is lower in Gdansk region than currently published.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12602272

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  2 in total

1.  Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR.

Authors:  Krzysztof Lukaszuk; Joanna Liss; Izabela Wozniak; Janusz Emerich; Czesław Wójcikowski
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

2.  HPV-type distribution and reproducibility of histological diagnosis in cervical neoplasia in Poland.

Authors:  Andrzej Nowakowski; Sabrina Collas de Souza; Robert Jach; Dominique Rosillon; Alicja Książek; Katsiaryna Holl
Journal:  Pathol Oncol Res       Date:  2014-12-30       Impact factor: 3.201

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.